StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
RBC Capital on Biogen (BIIB): 'CMS Makes It Clear - Leqembi Will Be Broadly Reimbursed - Should Reduce Overhang'
April 26, 2023 3:16 PM
RBC Capital analyst Brian Abrahams reiterated an Outperform rating and $340.00 price target on Biogen (NASDAQ: BIIB).The analyst comments "We ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Hot Comments
Next Articles
Biogen (BIIB) At Session High As RBC Says CMS Update Removes Overhang - Bloomberg
April 26, 2023 3:14 PM
Biogen (BIIB) PT Lowered to $346 at UBS
April 26, 2023 9:33 AM
Biogen (BIIB) PT Raised to $325 at Oppenheimer
April 26, 2023 8:00 AM
Biogen (BIIB) PT Lowered to $321 at Needham & Company
April 26, 2023 7:50 AM
Biogen (BIIB) PT Lowered to $340 at RBC Capital
April 26, 2023 6:48 AM
Biogen (BIIB) PT Lowered to $302 at Barclays
April 26, 2023 4:09 AM
Form 3 BIOGEN INC. For: Apr 17 Filed by: Keeney Adam
April 25, 2023 4:46 PM
Biogen (BIIB) PT Raised to $371 at Morgan Stanley
April 25, 2023 4:43 PM
Form 10-Q BIOGEN INC. For: Mar 31
April 25, 2023 4:22 PM
Biogen (BIIB) Announces FDA Grants Accelerated Approval for QALSODY for SOD1-ALS
April 25, 2023 3:05 PM
FDA Grants Accelerated Approval for QALSODY™ (tofersen) for SOD1-ALS, a Major Scientific Advancement as the First Treatment to Target a Genetic Cause of ALS
April 25, 2023 3:05 PM
FDA Grants Accelerated Approval for QALSODY™ (tofersen) for SOD1-ALS, a Major Scientific Advancement as the First Treatment to Target a Genetic Cause of ALS
April 25, 2023 3:04 PM
S&P 500 slumps as underwhelming quarterly results rattle sentiment
April 25, 2023 2:34 PM
PepsiCo, McDonald's and Spotify rise premarket; First Republic slumps
April 25, 2023 8:15 AM
Biogen (BIIB) tops Q1 expectations; Mizuho says MS sales weaker-than-expected
April 25, 2023 7:52 AM
Biogen (BIIB) Tops Q1 EPS by 12c, Offers Guidance
April 25, 2023 7:04 AM
Biogen trims pipeline programs to cut costs, focus on Alzheimer's drug launch
April 25, 2023 7:02 AM
Form 8-K BIOGEN INC. For: Apr 25
April 25, 2023 7:02 AM
Biogen (BIIB) option implied volatility flat into quarter results
April 24, 2023 11:05 AM
Biogen (BIIB) April weekly 295 straddle into quarter results
April 24, 2023 5:16 AM
